The content is available as a PDF (2.2 MB).
. 2022 Jun 16;162(7):S-596–S-597. doi: 10.1016/S0016-5085(22)61411-2
Su1489: HUMORAL IMMUNOGENICITY OF THREE SARS-COV-2 MRNA VACCINE DOSES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Trevor Schell
, Keith Knutson
, Sumona Saha
, Arnold Wald
, Hiep S Phan
, Mazen Almasry
, Kelly Y Chun
, Ian C Grimes
, Megan Lutz
, Mary S Hayney
, Francis A Farraye
, Freddy Caldera
Trevor Schell
Find articles by Trevor Schell
Keith Knutson
Find articles by Keith Knutson
Sumona Saha
Find articles by Sumona Saha
Arnold Wald
Find articles by Arnold Wald
Hiep S Phan
Find articles by Hiep S Phan
Mazen Almasry
Find articles by Mazen Almasry
Kelly Y Chun
Find articles by Kelly Y Chun
Ian C Grimes
Find articles by Ian C Grimes
Megan Lutz
Find articles by Megan Lutz
Mary S Hayney
Find articles by Mary S Hayney
Francis A Farraye
Find articles by Francis A Farraye
Freddy Caldera
Find articles by Freddy Caldera
Issue date 2022 May.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9212516